Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.94
Delayed Data
As of May 25
 +0.07 / +2.44%
Today’s Change
1.65
Today|||52-Week Range
6.49
+68.97%
Year-to-Date
5 Reasons Why VIVUS (VVUS) Stock Should Be in Your Portfolio
May 24 / Zacks.com - Paid Partner Content
Orexigen (OREX) Obesity Drug Contrave Registers Slow Growth
May 17 / Zacks.com - Paid Partner Content